TUESDAY, Feb. 23, 2016 (HealthDay News) — A drug used to forestall mother-to-child HIV delivery during pregnancy competence delayed denunciation growth somewhat in children, a new investigate suggests.
Researchers followed some-more than 900 infants who were innate to HIV-positive mothers though were not putrescent by a AIDS-causing virus. All of a mothers took antiretroviral drugs during pregnancy. Some of a diagnosis regimens enclosed a drug called atazanavir (Reyataz), while others did not.
The infants underwent a customary exam of growth during 1 year of age. The 167 infants whose mothers took atazanavir during pregnancy had somewhat reduce denunciation and amicable growth scores than a 750 infants whose mothers did not take a drug.
But a investigate usually showed an organisation between atazanavir and denunciation delays in children, and did not infer a cause-and-effect link.
And a disproportion in amicable growth scores was poignant usually among infants whose mothers started antiretroviral therapy during a second or third trimester of pregnancy. This competence be since women who started holding atazanavir during a initial trimester switched to a opposite antiviral drug fast after in pregnancy, a researchers suggested.
Scores in mental, earthy and behavioral growth were identical for infants whose mothers took atazanavir and those whose mothers did not, combined lead researcher Ellen Caniglia, from Harvard’s T.H. Chan School of Public Health in Boston.
The investigate was published online recently in a biography AIDS.
Previous investigate has suggested denunciation growth delays in infants whose mothers took atazanavir during pregnancy, and these commentary supplement to those concerns, a researchers pronounced in a biography news release.
Further studies are indispensable to establish either these denunciation and amicable growth delays final over a age of 1, how atazanavir competence means these delays, and either a delays competence be related to another drug called tenofovir (Viread), that is typically used alongside atazanavir.
The formula of a investigate “may be useful in diagnosis formulation for women with HIV infection,” a researchers concluded.
The U.S. Office on Women’s Health has some-more on pregnancy and HIV/AIDS.
SOURCE: AIDS, news release, Feb. 22, 2016
Last Updated: Feb 23, 2016
Copyright © 2016 HealthDay. All rights reserved.